NEW YORK / Jun 20, 2024 / Business Wire / DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced that management is participating in the iAccess Alpha Buyside Best Ideas Summer Conference 2024 on June 25 and 26, 2024. Lee Beinstock, DocGo’s Chief Executive Officer, will deliver a company presentation at 2:00 PM Eastern Time on June 25 and host one-on-one meetings the following day, June 26.
iAccess Alpha hosts virtual investor conferences, where presenting companies are recommended by a network of investors. The conference format spans two days, with company webcast presentations on day one, followed by one-on-one meetings with company management teams on day two.
To learn more about the iAccess Alpha Buyside Best Ideas Summer Conference 2024 on June 25 and 26, 2024 or to register and schedule a one-on-one meeting with DocGo, please visit the conference website https://www.iaccessalpha.com/home.
The presentation will be webcast live and available for replay here.
The webcast of DocGo’s presentation will also be available on the investor relations section of DocGo’s website at https://ir.docgo.com/.
About DocGo
DocGo is leading the proactive healthcare revolution with an innovative care delivery platform that includes mobile health services, remote patient monitoring and ambulance services. DocGo is helping to reshape the traditional four-wall healthcare system by providing high quality, highly accessible care to patients where and when they need it. DocGo’s proprietary technology and dedicated field staff of certified health professionals elevate the quality of patient care and drive business efficiencies for facilities, hospital networks and health insurance providers. With Mobile Health, DocGo empowers the full promise and potential of telehealth by facilitating healthcare treatment, in tandem with a remote physician, in the comfort of a patient’s home or workplace. Together with DocGo’s integrated Ambulnz medical transport services, DocGo is bridging the gap between physical and virtual care. For more information, please visit www.docgo.com.
| Last Trade: | US$2.31 |
| Daily Change: | 0.11 5.00 |
| Daily Volume: | 652,167 |
| Market Cap: | US$234.530M |
February 27, 2025 February 19, 2025 February 10, 2025 December 18, 2024 | |
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MORE
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MORE
